News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,496 Results
Type
Article (39209)
Company Profile (282)
Press Release (650005)
Section
Business (203937)
Career Advice (1999)
Deals (35384)
Drug Delivery (89)
Drug Development (80873)
Employer Resources (168)
FDA (16110)
Job Trends (14814)
News (344707)
Policy (32452)
Tag
Academia (2530)
Alliances (49245)
Alzheimer's disease (1285)
Approvals (16070)
Artificial intelligence (159)
Bankruptcy (354)
Best Places to Work (11596)
Biotechnology (199)
Breast cancer (201)
Cancer (1487)
Cardiovascular disease (119)
Career advice (1665)
Cell therapy (307)
Clinical research (64892)
Collaboration (551)
Compensation (302)
COVID-19 (2547)
C-suite (129)
Data (1459)
Diabetes (185)
Diagnostics (6190)
Earnings (85007)
Employer resources (146)
Events (110315)
Executive appointments (459)
FDA (16862)
Funding (501)
Gene therapy (213)
GLP-1 (615)
Government (4336)
Healthcare (18736)
Infectious disease (2643)
Inflammatory bowel disease (112)
Interviews (309)
IPO (16376)
Job creations (3625)
Job search strategy (1418)
Layoffs (424)
Legal (7866)
Lung cancer (220)
Manufacturing (214)
Medical device (13226)
Medtech (13231)
Mergers & acquisitions (19246)
Metabolic disorders (487)
Neuroscience (1636)
NextGen: Class of 2025 (6505)
Non-profit (4471)
Northern California (1848)
Obesity (278)
Opinion (185)
Parkinson's disease (105)
Patents (130)
People (56598)
Phase I (20195)
Phase II (28579)
Phase III (21293)
Pipeline (603)
Postmarket research (2561)
Preclinical (8552)
Radiopharmaceuticals (238)
Rare diseases (280)
Real estate (5893)
Regulatory (21759)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1590)
Startups (3565)
United States (16362)
Vaccines (571)
Weight loss (192)
Date
Today (104)
Last 7 days (871)
Last 30 days (2136)
Last 365 days (35019)
2025 (1347)
2024 (35251)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35020)
2017 (32110)
2016 (31482)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (713)
Arizona (202)
Asia (37364)
Australia (6100)
California (4172)
Canada (1530)
China (352)
Colorado (188)
Connecticut (199)
Europe (80024)
Florida (587)
Georgia (141)
Illinois (409)
Indiana (237)
Maryland (673)
Massachusetts (3230)
Michigan (180)
Minnesota (312)
New Jersey (1170)
New York (1186)
North Carolina (777)
Northern California (1848)
Ohio (150)
Pennsylvania (985)
South America (1093)
Southern California (1590)
Texas (600)
Utah (118)
Washington State (425)
689,496 Results for "hygieia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors
Hygieia is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.
May 2, 2023
·
3 min read
BioMidwest
UAT Group Subsidiary Launches New Hygieia Ageless Skin Care Line
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, LLC, is re-branding and expanding its highly lauded Hygieia Skin care product suite as “Hygieia Ageless”.
August 12, 2022
·
4 min read
BioMidwest
Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program
Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program.
December 13, 2022
·
3 min read
BioMidwest
Hygieia announces new CPT codes for autonomous insulin dose titration
Hygieia, a digital therapeutics company for insulin therapy, announces the American Medical Association (AMA) CPT Editorial Panel has approved two new Category III codes for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav® Technology.
July 26, 2022
·
3 min read
BioMidwest
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, is expanding on its Hygieia product line with the launch of a new premium revitalizing eye gel.
August 2, 2022
·
4 min read
Business
Hygieia adds Metro Detroit Endocrinology Center as clinical partner for its d-Nav® Insulin Management Program
Hygieia adds Metro Detroit Endocrinology Center as clinical partner for its d-Nav® Insulin Management Program.
August 30, 2022
·
3 min read
Business
Diabetes Technology Leader and Global Business Executive Doug Lawrence Joins Hygieia as CEO
Hygieia, a digital therapeutics company for insulin therapy, has appointed Doug Lawrence its chief executive officer, responsible for leading operations, development, and global growth of the company and its d-Nav® Insulin Management Program.
August 23, 2022
·
4 min read
Business
Hygieia adds clinical partners in New York and North Carolina to its d-Nav® Insulin Management Program
Hygieia, a provider of digital therapeutics for insulin management, has added Endocrine Associates of West Village P.C. in Manhattan and Long Island City, NY, and Physicians East in Greenville, NC, as clinical partners.
September 12, 2022
·
4 min read
Biotech Beach
Hygieia Launches d-Nav® Clinical Partnership Program at AACE Annual Meeting
Hygieia, a digital therapeutics company, announced the official launch of its d-Nav Clinical Partnership Program for endocrinology practices treating patients with type 2 diabetes.
May 12, 2022
·
3 min read
BioMidwest
Digital Insulin Management Company Hygieia Closes on $17 Million Series B Investment Round
Hygieia , a digital health company for insulin management, has closed on an initial $17 million Series B investment round, led by Israeli venture capital firm Firstime Ventures, and with participation from existing investors.
December 2, 2021
·
3 min read
1 of 68,950
Next
